We have investigated the function and mechanisms of the CARM1-SNF5 complex in T3-dependent transcriptional activation. Using specific small interfering RNAs (siRNA) to knock down coactivators in HeLa α2 cells, we found that coactivator associated arginine methyltransferase 1 (CARM1) and SWI/SNF complex component 5 (SNF5) are important for T3-dependent transcriptional activation. The CARM1-SWI/SNF chromatin remodeling complex serves as a mechanism for the rapid reversal of H3-K9 methylation. Importantly, siRNA treatment against CARM1 and/or SNF5 increased the recruitment of HMTase G9a to the type 1 deiodinase (D1) promoter even with T3. Knockingdown either CARM1 or SNF5 also inhibited the downregulation of histone macroH2A, which is correlated with transcriptional activation. Finally, knocking down CARM1 and SNF5 by siRNA impaired the association of these coactivators to the D1 promoter, suggesting functional importance of CARM1-SNF5 complex in T3-dependent transcriptional activation.
Introduction
Thyroid hormone receptors (TRs) can bind to target promoter as monomers, homodimers, or heterodimers with retinoid X receptor (RXR) . TRs can positively or negatively regulate transcription dependent on the presence or absence of hormones and the presence of a positive or negative thyroid hormone response element (TRE vs nTRE) in its target genes (O'Shea and Williams, 2002) . In the absence of ligand, TR/RXR heterodimers bind to TREs and actively repress transcription. The repression by unliganded TR/RXR is largely mediated through the recruitment of corepressor proteins such as silencing mediator for retinoic acid receptor and thyroidhormone receptor (SMRT) and nuclear hormone receptor co-repressor (N-CoR) (Guenther et al., 2000; Yoon et al., 2003a) . Binding of T3 to TR is believed to induce conformational changes of the receptor, which in turn lead to the release of corepressors and the recruitment of coactivators. Compared to repression by unliganded TR, transcriptional activation by liganded TR is much more complex. First, hormone-dependent activation appears to involve a significantly larger number of cofactors. The current list of nuclear hormone receptor (NR) coactivators contains more than 200 proteins (Narr et al., 2001, McKenna and O'Malley, 2002) . Although it is extremely unlikely that all these putative coactivators are required for activation by nuclear receptors, studies from many laboratories provide evidence that many coactivators are required and act in concert to mediate transcriptional activation by nuclear receptors (Rosenfield and Glass, 2001 ; Lee et al., 2002) . A number of coactivators contain the signature motif LXXLL sequences (X, any amino acid) that interact with the ligand-binding domain of NRs in a liganddependent manner (Heery et al., 1997; McInerney et al., 1998) .
Based on the studies of CREB-binding protein (CBP) and E1A-binding protein, 300-kDa (p300) knockout mice (Kawasaki et al., 1998; Yao et al., 1998) , we know that CBP and p300 are critically important for activation by RAR. Their intrinsic histone acetyltrasferase (HAT) activity is likely critical for their ability to enhance activation by many NRs (Kraus et al., 1999; Yi et al., 2007) , although in some cases the HAT activity of p300/CBP-associated factor (PCAF) may be preferentially used (Korzus et al., 1998) . The general requirement for CBP/p300 is consistent with the notion that histone acetylation is critically important for transcriptional activation from repressive chromatin. In this regard, the major function of the steroid hormone receptor coactivator (SRC) family, which interacts directly with liganded receptors, is believed to serve as bridging molecules to recruit CBP/p300 and other coactivators such as CARM1 (Xu and Li, 2003) In addition to histone acetylation, histone methylation by CARM1 has been shown to facilitate hormone-dependent activation by NRs (Chen et al., 1999; Wang et al., 2001) . CARM1 methylates histone H3 at Arg 2, 17 and 26 . CARM1 cooperates synergistically with the SRC family of coactivators and CBP/p300 to enhance transcriptional activation by NRs in transient transfection assays (Chen et al., 2000) . In addition, CARM1 associates with the SWI/SNF complex and this association seems to enhance the HMT activity of CARM1 (Xu et al., 2004) . Finally, CARM1 null mice die perinatally and estrogen-responsive gene expression is aberrant in Carm1-/-fibroblasts and embryos, thus indicating a critical role for CARM1 in mediating transcriptional regulation by estrogen receptors (Yadav et al., 2003) . However, given that CARM1 can methylate not only histones but also other proteins, it is not clear whether histone methylation by CARM1 is critically important for transcriptional activation by NRs. In addition to the enzymes that covalently modify histones, the ATP-dependent chromatin remodeling factor, SWI/SNF, also has a critical role in transcriptional activation by NRs (Chiba et al., 1994; Wong et al., 1995) . Human SWI/SNF is heterogeneous and known to contain either Brm or its related protein Brg1, the ATPase subunits of the complexes (Wang et al., 1996) . In transient transfection and in vitro transcription assays, both hBrm and hBrg1 can facilitate transcriptional activation by glucocorticoid receptor (GR), estrogen receptor (ER), and retinoic acid receptor (RAR) (Dilworth et al., 2000; DiRenzo et al., 2000) . Accumulated evidence indicates that the coactivators CARM1 and ATP-dependent chromatin remodeling factor SWI/ SNF have critical functions in transcriptional activation by nuclear receptors. However, the underlying mechanism for requirement of various chromatin remodeling factors remains obscure.
In this study, we have investigated the function and mechanisms of the CARM1-SNF5 complex in T3-dependent transcriptional activation. We found that CARM1 and SNF5 to a large extent are important for T3-dependent transcriptional activation. The CARM1-SWI/SNF chromatin remodeling complex serves as a mechanism for the rapid reversal of H3-K9 methylation. Finally, knocking down CARM1 and SNF5 by siRNA impaired the association of coactivator P300 to the D1 promoter, suggesting functional importance of CARM1-SNF5 complex in T3-dependent activation.
Materials and Methods

Cell culture and siRNA
Cell culture and siRNA treatment were carried out essentially as previously described (Yoon et al., 2003b (Yoon et al., , 2005 . For transfection of siRNAs, HeLa α2 cells were first cultured in DMEM supplemented with 10% charcoal-stripped serum for three days and then transfected at a cell confluency of ~40-50% using Lipofectamine 2000 with amounts of siRNA as indicated by the manufacturer's instructions. Two days after transfection, cells were collected and processed for western analysis, RT-PCR, or chromatin immunoprecipitation (ChIP) as indicated. For experiments with T3, α2 cells were initially seeded at a density of 4 × 10 5 cells/100 mm tissue culture dish. After a 24-h incubation, the culture media was replaced with DMEM with 10% charcoal-stripped FCS (CS-FCS) (Gemini Bio-Products) for three days followed by replacement with fresh CS-FCS supplemented with 10 nM T3 for up to six h. For the experiments involving both siRNAs and T3, T3 was added two days after siRNA transfection and incubated for one h or as indicated in the ChIP assays and six h for RT-PCR analysis. The siRNAs for SNF5, CBP, PCAF, PRMT5, BRG1, ASC2 and Brm were chemically synthesized (Dharmacon Research, Lafayette, Co), de-protected and annealed according to the manufacturer's instruction. The siRNA sequences used are as follows: SNF5-1, AAUGUU-CCGAGGUUCUCUGUA; SNF 5-2, AAUGGCAAC-GAUGAGAAGUAC; CBP-1, AAACTCGTCCAAG-CCATCTTCA; CBP-2, AAACGGAGGTCGCGTTT-ACAT; CBP-3, AACGGAGGTCGCGTTTACATA; PCAF-1, AACCTGTGGTTGAAGGCTCTT; PCAF-2, AATCGCCGTGAAGAAAGCGCA; PCAF-3, AA-ACGAACTCTAATCCTCACT; PRMT5-1, AACGTG-TATGGCTTCGACATG; PRMT 5-2, AAAGGAGGT-GGACATCTATAC; BRG1-1, AATGCCAAGCAAG-ATGTCGAT; BRG1-2, AAATACCTCAGGCTTGAT-GGA; BRG1-3, AAATCGAGAAGGAGGATGACA; ASC2-1, AAGTGGTCCAGGAATAATAAG; ASC2-2, AATAAGGATGTCACGCTAACG; ASC2-3, AAA-GTTACAGGCTCTCTTGAG; Brm-1, AACGGAAT-CTTAGCCGATGAA; Brm-2, AAAATTGAGAGCG-ACTAATCA; Brm-3, AAGAATTACCAGAATACTA-TG. The pre-designed siRNAs for p300, CARM1, p68, SRC1, SRC2 and SRC3 were obtained from Dharmacon. The efficiency of siRNA knockdown was determined by western analysis using the corresponding specific antibodies.
ChIP assays
For ChIP assays, we first isolated chromatin as previously described (Yoon et al., 2005) . In brief, approximately 2 × 10 9 α2 cells in 150-mm dishes were first treated with PBS containing 1% formaldehyde for 10 min, washed twice with PBS, and then incubated with 100 mM Tris (pH 9.4) and 10 mM DTT at 30 o C for 15 min. The cells were then rinsed twice with PBS and resuspended in 600 µl of Sol A buffer [10 mM Hepes (pH 7.9), 0.5% NP-40, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT] by pipetting. After a short spin (5 min at 3,000 rpm), the pellets were resuspended in Sol B [20 mM Hepes (pH 7.9), 25% glycerol, 0.5% NP-40, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA] containing protease inhibitors followed by vigorous pipetting in order to extract the nuclear proteins. After centrifugation at 13,000 rpm for 30 min, the nuclear pellets were resuspended in IP buffer (1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 150 mM NaCl and protease inhibitors) and sonicated to break the chromatin into fragments with an average length of 0.5-1 kb. The ChIP assays were then performed with the indicated antibodies essentially as previously described, though, SDS was omitted in all buffers. The antibodies against acetylated p300, G9a, Suv39H1, TR, Dimethyl R17-H3, AcH3, and TrimethylK9-H3 were purchased from Upstate Biotechnology. The antibody against LSD1 and Brm1 were obtained from Santa Cruz Biotechnology. The antibodies against JHDM2A, SNF5 and macroH2A were kindly provided by Dr. Wong J (East China Univesity). The antibodies against SRC1, SRC2, SRC3, p300 and SNF5 were kindly provided by Dr. Qin J (Baylor College of Medicine). The primers used for ChIP analysis were previously described (Yoon et al., 2005) .
RNA extraction and RT-PCR
Total RNA was isolated from α2 cells using an RNeasy Mini kit (Qiagen, Tokyo, Japan), according to the manufacturer's specifications. Total RNA from each sample was reverse-transcribed with random primers using a StrataScript TM reverse transcriptase kit (Stratagene, La Jolla, CA) followed by quantitative PCR analysis. Primers for ADRB2 amplification were 5'-GGATCGCTACTT-TGCCATTACTTCACCTTTCA-3' and 5'-CCCCGT-CCGCCCATCCTGCTCCAC-3'. Primers for BCL3 amplification were 5'-ACGCCGTGGAAAACAACA-GCCTTAGCAT-3' and 5'-GAGCGGCGTGTCGTT-GTGGCAGTTCTTGAG-3'. Primers for FAS amplification were 5'-CATCGGGCACGTGGGCATTTT-G-3' and 5'-GGTCCCGCTGGCTGTCCCTGTCC-3'. Primers for D1 amplification were 5'-AACCCCC-ATTTCAGCCACGACAAC-3' and 5'-ATTCAGCAC-CAGTGGCCTATTACCTT-3'. Primers for GAPDH amplification were 5'-CGCGGGGCTCTCCAGAAC-ATCATCC-3' and 5'-CTCCGACGCCTGCTTCACC-ACCTTCTT-3'. PCR products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining.
Real-time PCR analysis
The RT-PCR analysis and quantification were performed with Taqman One-Step RT-PCR Master Mix Reagents or SYBR Green PCR Master mix Reagents [depending on the target RNA (see below)] on an ABI Prism 7700 Sequence Detection System (Applied biosystem, Foster city, CA). The singularity and specificity of amplifications were checked by Dissociation Analysis Software. All samples were normalized to 18S rRNA (Applied biosystem). Primer sequences for amplification of the D1 RNA used in qRT-PCR were (F 5'-AG-CCCATCTACTGCTGGCC-3', R 5'-TGTAGTTCCA-AGGGCCAGATTT-3', and probe 5'-FAM-AGGC-TCTACATAATCCAGGAGGGCAGGA-TAMRA-3').
All reactions were performed in triplicate. Relative expression levels and SDs were calculated using the comparative method. (A) HeLa α2 cells were transfected with control (scrambled) siRNA or siRNA against coactivators at the concentration indicated. Three days after treatment, whole cell extracts were prepared and the levels of each protein were determined by western blot. Western blot results for HDAC3 served as specificity controls.
Results
Both CARM1 and SNF5 are important for T3-dependent activation of the D1 gene
Transcription is a complex, multi-step process involving a large number of cofactors that affect chromatin remodeling, formation of RNA polymerase II preinitiation complex (PIC), transcription elongation and the RNA processing (Levine and Tjian, 2003) . To successfully transcribe a gene, each essential cofactor must be recruited to the promoter in a dynamic fashion to fulfill its specific function and allow the next step to proceed.
Using Xenopus laevis oocytes, we previously showed that transcriptional activation by liganded TR is coupled with not only increased acetylation on H3 and H4 but also a robust decrease in H3-K9 methylation. Furthermore, the pronounced effect on histone acetylation was repeatedly observed upon T3 treatment, presumably as a combined result of corepressor complex dissociation and subsequent active recruitment of coactivators by liganded TR (Li et al., 2002) .
To address which coactivators are required for dynamic regulation between acetylation and K9-methylation of H3, we first developed specific siRNAs against various coactivators. To test the effect and specificity of siRNA constructs, HeLa α2 cells were transfected with three different siRNAs per target coactivator. Two days after transfection, HeLa α2 cells were collected, and the effect of siRNA treatment was analyzed by western blotting. Each siRNA treatment clearly silenced the expression of their corresponding target proteins. The siRNAs against CARM1, p300 and Brm worked more efficiently than the siRNAs against p68, BRG1 and SNF5 ( Figure 1A) . As a control, we measured the levels of HDAC3, a corepressor for nuclear receptors, which showed no significant change after any siRNA treatment. In fact, we tested and found none of the siRNAs used had any significant cross effect. For instance, siRNA against BRG1 selectively reduced the level of BRG1 protein but had no effect on SNF5, and vice versae (data not shown).
Having established the specific 'knock-down' effects caused by each siRNA, we next tested the effect of these specific siRNAs on TR activation. To assess which coactivators are required for T3-dependent activation, we examined the effect of knocking down each of them on D1 expression, the TR target gene in HeLa α2 cells. For this purpose, HeLa α2 cells were treated with siRNA specifically against coactivators and a control siRNA as shown in Figure 1B . Three days after siRNA treatment, T3 (50 nM) was added to the tissue cultures and incubated for an additional six h. Cells were then harvested and the level of D1 gene expression was determined by quantitative real time PCR. In each experiment, the effectiveness of the siRNA knock-down was confirmed by western analysis. Importantly, knock-down of CARM1 and SNF5 significantly crippled T3-dependent activation of the D1 gene, indicating that CARM1 and SNF5 are critically important for transcriptional activation by TR ( Figure 1B ). To assess whether CARM1 and SNF5 are generally required for T3-dependent activation, we tested the effect of knocking down CARM1 and SNF5 on the expression of FAS, ADRB2, and BCL3, another TR target genes in HeLa α2 cells. Three days after siRNA treatment, the cells were treated with 10 nM T3 for six h, and the levels of FAS, ADRB2 and BCL3 gene expression were determined by RT-PCR. While treatments with siRNAs against coactivators did not alter the transcription level of the GAPDH gene, a significant effect was observed for most of the TR target genes ( Figure  1C ). In this case, the knockdown of CARM1 and SNF5 in general led to a repression of liganded TR-mediated transcription from all three TR target genes, although the extent of decreased expression was gene-dependent. Together, we conclude, at least for the genes we have tested, that CARM1 and SNF5 are generally required for Figure 2 . Both CARM1 and SNF5 are required for the rapid reversal of H3-K9 methylation. HeLa α2 cells were transfected with control (scrambled) siRNA or siRNA against coactivators at the concentration indicated. The cells were then treated with T3 for 6 h, after which the levels of acetylated and methylated lysine 9 of H3 were determined by ChIP assays using the antibodies indicated.
T3-dependent transcriptional activation in mammalian cells.
Chromatin remodeling by CARM1-SWI/SNF is essential for reversal of H3-K9 methylation
The presence of K9 methylated H3 (mH3-K9) in genes repressed by unliganded TR raises question as to how the liganded receptor overcomes this repressive activity during T3-dependent activation. As shown in Figure 2 , we found by ChIP assay that the level of mH3-K9 in the D1 promoter was rapidly decreased upon T3 treatment. As knock-down of CARM1 and SNF5 significantly crippled T3-dependent activation of the D1 gene, we next determined whether chromatin remodeling by CARM1-SWI/ SNF is essential for reversal of H3-K9 methylation. To do this, HeLa α2 cells were treated with siRNA specifically against coactivators and a control siRNA as shown in Figure 1A . Three days after siRNA treatment, T3 (10 nM) was added to the tissue cultures and incubated for an additional six h. Cells were then harvested and histone modification was determined by ChIP assays. ChIP results showed that treatment of cells with T3 led to a significant increase of acetylated H3 levels. T3 treatment also resulted in a reduction of mH3-K9 in the D1 target. Interestingly, knocking down either CARM1 or SNF5 led to a decrease in histone acetylation even of T3 (Figure 2 ). Knocking-down P300 induced a robust decrease of acetylation, as expected. Taken together, these results support the idea that chromatin remodeling by CARM1-SWI/SNF serves as a mechanism for the rapid reversal of H3-K9 methylation.
We next examined the relationship between knocking-down CARM1 or SNF5 and increase of methyl K9-H3 in the presence of T3. Chip patterns obtained on chromatin prepared from α2 cells, treated six h with T3 after 3 days of hormonedeprivation, demonstrate that CARM1, SRC, p300 and SNF5 coexist with liganded-TR in the D1 promoter ( Figure 3A) . Furthermore, histone methyltransferase, G9a, but not Suv39H1, was recruited to D1 promoter in the absence of T3. In contrast to HMTase, the histone demethylase LSD1 and JHDM2A were not found on the D1 promoter regardless of T3, implying the presence of other demethylases. Importantly, siRNA treatment against CARM1 and/or SNF5 increased the recruitment of HMTase, G9a compared with control siRNAs. This data suggested that the increased recruitment of G9a by knocking-down of CARM1-SNF5 complex reversed severely T3-induced decrease of methyl K9-H3 ( Figure 3B ).
The functional importance of the CARM1-SNF5 complex in histone code dynamics
The CARM1 methyltransferase catalytic function is required for receptor transactivation (Chen et al., 1999) with methylation at R17 of histone H3 serving as a marker of active hormone response elements. Recently, the association of ATPremodeling factors with CARM1 revealed a new arm in the nuclear hormone-signaling cascade (Xu et al., 2004) . To study the effect of mR17-H3 on the modulation of histone code, we knocked down CARM1 and SNF5 individually or in combination by siRNA and then tested the effect on histone modifications including mR17-H3, acetylation of H3, mK9-H3 and mH2A2. As shown in Figure 4 , we found that knocking down CARM1 and SNF5 affected the up-regulation of methylation of arginine-17 and acetylation of H3 as expected. Knocking-down the CARM1-SNF5 complex did not appear to affect the recruitment of TR. The down regulation of mK9-H3 was abolished by treatment with siCARM1 or siSNF5. Interestingly, knockingdown either CARM1 or SNF5 inhibited the downregulation of histone macroH2A, which is correlated with transcriptional activation (Valley et al., 2006) . Finally, these data indicate that the functional importance of the CARM1-SNF5 complex in histone code dynamics is correlated with transcriptional activation. 
The CARM1-SNF5 complex is required for the ordered recruitment of coactivators in TR-mediated transcriptional activation
CARM1 is a coactivator that could have a role in recruiting SWI/SNF. CARM1 interacts with the SRC coactivator family and CBP/p300 (Schurter et al., 2001) . In addition, CARM1 has been shown recently to associate with SWI/SNF in a large protein complex termed NUMAC (Xu et al., 2004) . Thus, CARM1 could function as a bridging factor between SRC-CBP/p300 and SWI/SNF. To determine if CARM1 and SNF5 affects coactivator recruitment, we used a ChIP assay to determine how knocking down of CARM1 and/or SNF5 affects the recruitment of the following coactivators: members of the SRC family (SRC-1, 2 and 3), CBP/p300, and TRAP/Mediator complex. These coactivators have been well characterized and are known to have critical roles in transcriptional activation by NRs. Furthermore, a recent study showed that all of these coactivators were recruited to the D1 gene promoter by TR (Metivier et al., 2003) . We and others have shown by ChIP assay that SRC-1, CBP/p300, the TRAP/Mediator complex and SWI/SNF were recruited to the target promoters by liganded TR (Huang et al., 2003; Yoon et al., 2005) . ChIP assay also showed that their recruitment is affected after knocking down CARM1, which had little effect on SRC-2 ( Figure  5 ). Whether this result reflects a saturated recruitment of SRC-2 is not known. Together, the CARM1-SNF5 complex is a key bridging factor required for the ordered recruitment of coactivators in TR-mediated activation.
Discussion
Accumulated evidence indicates that coactivators CARM1 and the ATP-dependent chromatin remodeling factor SWI/SNF have critical functions in transcriptional activation by nuclear receptors. However, the underlying mechanism for requirement of various chromatin remodeling factors remains obscure. CARM1 cooperates synergistically with the SRC family of coactivators and CBP/p300 to enhance gene activation by NRs as observed in transient transfection assays (Chen et al., 2000) . In addition, CARM1 associates with the SWI/SNF complex and this association seems to enhance CARM1's HMT activity. Finally, CARM1 null mice die perinatally and estrogen-responsive gene expression is aberrant in Carm1-/-fibroblasts and embryos, indicating a critical role for CARM1 in mediating transcriptional regulation by estrogen receptors. However, why histone methylation by CARM1 is important for transcription remains to be elucidated.
To investigate the functional importance of coactivators in T3-dependent activation, we first attempted to generate siRNAs against coactivators as indicated (Figure 1 ). Using these siRNAs, we then analyzed the effect of knocking-down coactivators on D1 expression. Knocking down CARM1 and SNF5 significantly impaired T3-dependent activation by TR. Next, to substantiate whether this result was gene specific or a general mechanism, we tested the effect of knocking down CARM1 and SNF5 on the expression of the other three TR target genes in HeLa α2 cells. As shown in Figure  1C , we found that both CARM1 and SNF5 are generally required for T3-dependent activation. siRNAs against hBrg1 and hBrm also reduced T3-dependent activation, but to lesser extent than did siSNF5, presumably because of the functional redundancy between hBrg1 and hBrm. In addition, CARM1 associates with the SWI/SNF complex and this association seems to enhance CARM1's HMT activity (Xu et al., 2004) . Finally, our data indicate that the CARM1-SWI/SNF complex is important for T3-dependent transcriptional activation in mammalian cells.
Histone methylation is known to be stable metabolically (Waterborg, 1993; Kang et al., 2007) . The presence of K9 methylated H3 (mH3-K9) in genes repressed by unliganded TR raises question as to how a liganded receptor overcomes this repressive activity during T3-dependent activation. Surprisingly, as shown in our data (Figure 2) , we found by ChIP assay that the level of mH3-K9 in the D1 promoter decreased rapidly upon T3 treatment. Here we tested the hypothesis that chromatin remodeling by SWI/SNF serves as a mechanism for the rapid reversal of H3-K9 methylation. Finally, we identified that CARM1-SNF5 is required for the rapid reversal of H3-K9 methylation by using siRNAs and ChIP assay. It is unclear why a knocking-down of CARM1 and/or SNF5 increased the level of methyl K9-H3. CARM1 has been shown recently to associate with SWI/SNF in a large protein complex termed NUMAC. In addition, nucleosome unfolding at transcriptionally active promoter by chromatin remodeling complexes have been reported (Boeger et al., 2003; Adkins et al., 2004) . Based on these studies, the nucleosome clearance presumably correlates with the change of histone methylation and initiation of transcription. As shown in Figure  3B , we found that siRNA treatments against CARM1 and/or SNF5 increased the recruitment of HMTase, G9a. The enhanced recruitment of G9a reversed greatly T3-induced decrease of methyl K9-H3. Taken together, we believe the chromatin remodeling by SWI/SNF is likely to be at lease one of the mechanisms for rapid removal of the repressive mH3-K9 marker during T3-dependent activation, although the involvement of other mechanisms such as demethylation cannot be excluded.
Coactivator that could have a role in recruiting SWI/SNF is CARM1. CARM1 interacts with the SRC family of coactivators and CBP/p300 (Schurter et al., 2001) . In addition, CARM1 has been shown recently to associate with SWI/SNF in a large protein complex termed NUMAC. Thus, CARM1 could function as a bridging factor between SRC-CBP/p300 and SWI/SNF. We employed siCARM1 and/or siSNF5 to test whether knocking down CARM1 affects the recruitment of coactivators involved in T3-dependent activation as described. Knocking down the CARM1-SNF5 complex impaired targeting of coactivators to TR target genes, but had little effect on SRC-2. Together, the CARM1-SNF5 complex is important for the recruitment of a coactivator involved in T3-depedent activation.
In summary, we demonstrated that the CARM1 complex is generally required for transcriptional activation by TR. In principle, as transcription is a multi-step process, CARM1 could exert its function at one or more of the essential steps. First, it could be required for the recruitment of other essential coactivators. Second, it could be required for the assembly of the pol II preinitiation complex. Third, it could be required for the transition from transcription initiation to elongation. One limitation in dissecting the role of CARM1 as outlined above is that it would be difficult to pinpoint the exact function of CARM1 even though knocking down CARM1 could have multiple effects on transcription. For instance, as knocking down CARM1 affects coactivator recruitment, it also might affect recruitment of basal transcriptional machinery and/or transcriptional elongation. In this case, the effect on these subsequent steps could be the indirect effect of the coactivator(s) being affected. Despite this limitation, this study should yield significant insight into the mechanism by which the CARM1-SNF5 complex affects transcription.
